Applied Genetic Technologies Corp.
(NASDAQ : AGTC)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Do You Like Swing Trading?
Learn how we win with easy 3-5 day holds.
Be 'active' in the market while NOT being tied to your desk.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
AMGNAmgen Inc.
0.32%183.561.1%$862.86m
GILDGilead Sciences, Inc.
-0.30%80.700.9%$827.80m
CELGCelgene Corporation
0.96%94.751.2%$768.18m
JUNOJuno Therapeutics, Inc.
1.97%86.6513.5%$580.24m
BIIBBiogen Inc.
0.34%288.431.2%$511.68m
REGNRegeneron Pharmaceuticals, Inc.
-1.14%319.372.7%$396.19m
VRTXVertex Pharmaceuticals Incorporated
-1.54%158.501.9%$353.82m
ALXNAlexion Pharmaceuticals, Inc.
-0.58%118.162.0%$255.13m
NKTRNektar Therapeutics
1.06%84.346.0%$249.69m
ILMNIllumina, Inc.
0.01%226.583.5%$230.72m
BLUEBluebird Bio, Inc.
2.31%210.1916.1%$196.38m
AAgilent Technologies, Inc.
1.44%72.101.5%$178.13m
INCYIncyte Corporation
0.55%85.982.5%$154.96m
BMRNBioMarin Pharmaceutical Inc.
0.98%84.674.4%$122.36m
EXASExact Sciences Corporation
-0.34%47.8526.0%$117.77m

Company Profile

Applied Genetic Technologies Corp. is a clinical-stage biotechnology company, which engages in the development of gene therapy products designed to transform the lives of patients with severe diseases in ophthalmology. Its product candidates are designed to treat X-linked retinoschisis, Achromatopsia, and X-linked retinitis pigmentosa. The company was founded by Richard Jude Samulski, Nicholas Muzyczka, William W. Hauswirth, Terence R. Flotte, and Barry J. Byrne on January 19, 1999 and is headquartered in Alachua, FL.